Related Experiment Video

Updated: Jul 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Ras oncogenes and their downstream targets

Krishnaraj Rajalingam1, Ralf Schreck, Ulf R Rapp

  • 1University of Würzburg, Institut für Medizinische Strahlenkunde und Zellforschung, Versbacherstr. 5, D-97078 Würzburg, Germany.

Biochimica Et Biophysica Acta
|April 13, 2007
PubMed

Insights

RAS proteins, key regulators of cell signaling, are crucial in cancer. This review covers RAS evolution, activation, effector pathways, and therapeutic strategies targeting RAS mutations.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • RAS proteins are small GTPases regulating diverse cellular processes.
  • RAS oncogenes and their mutations are frequently found in human tumors, driving intense research.
  • Understanding RAS signaling is critical for cancer biology and therapy.

Purpose of the Study:

  • To review the biochemical properties and evolutionary history of RAS signaling.
  • To provide an overview of RAS isoform activation and effector pathways.
  • To summarize current therapeutic strategies targeting aberrant RAS signaling.

Main Methods:

  • Literature review and synthesis of existing research on RAS proteins.
  • Analysis of evolutionary pathways of RAS signaling.
  • Discussion of molecular mechanisms and therapeutic interventions.

Main Results:

  • RAS proteins are central to numerous signaling cascades.
  • Aberrant RAS signaling contributes to cancer development and progression.
  • Various strategies are being developed to target RAS pathways therapeutically.

Conclusions:

  • RAS signaling is a fundamental pathway in cell physiology and disease.
  • Targeting RAS offers a promising avenue for cancer treatment.
  • Future research includes microRNA modulation, stem cell roles, and network analyses.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...